Iterative Health
About Iterative Health
Iterative Health is a healthcare technology and services company that leverages artificial intelligence (AI) to accelerate clinical research and improve patient outcomes. The company operates a global network of community-based clinical research sites, connecting trial sponsors with healthcare providers to streamline enrollment and broaden patient access to investigational therapies. Their AI tooling, particularly SKOUT, which is rooted in computer-vision work in GI endoscopy, aims to enhance the efficiency of research for both sites and sponsors.
For physicians, Iterative Health’s offerings are designed to integrate research directly into everyday care settings. They provide infrastructure, insights, and connections to help partner sites expand their impact and grow sustainably. This includes specialized operations, staffing, and technology to empower research sites in therapeutic areas such as gastroenterology, hepatology, obesity, and cardiology. Their AI-powered tools assist in patient identification, trial management, and recruitment execution, aiming to reduce operational burden and deliver reliable results at scale. The company also offers Iterative U, an on-demand training platform with CE-certified courses for clinical research teams, to deepen expertise and share best practices.
Iterative Health’s technology, such as the SKOUT AI tooling, helps clinicians in detecting and diagnosing complex gastrointestinal conditions more effectively by interpreting endoscopic images and other data. This aims to enhance clinical decision-making and care coordination by transforming fragmented health data into clear, interpretable insights. By partnering with Iterative Health, physicians can offer research as a treatment option, improving patient outcomes and access to next-generation care.
Focus Areas
Business Intelligence
| Technology | AI-powered clinical research network, computer vision for GI endoscopy, multi-modal datasets, proprietary software algorithms |
What Physicians Need to Know
Iterative Health's AI-driven tools offer physicians enhanced capabilities in detecting, annotating, and scoring GI-related diseases, potentially leading to more accurate diagnoses and treatment decisions. Their SKOUT™ device can improve adenoma detection during colonoscopies, reducing variability in screenings. For physicians involved in clinical research, Iterative Health's network and AI-powered recruitment tools can streamline patient identification and trial processes, reducing administrative burden and accelerating access to novel therapies for patients. The company's focus on standardizing endoscopic assessments with AI can provide more consistent and objective measures of disease activity, which is crucial for both clinical trials and patient care.
Iterative Health's AI-powered tools are designed to integrate with existing clinical workflows, particularly in endoscopy, to augment clinical decision-making and provide evidence-based documentation. Their AI Recruitment technology integrates with clinical research teams to address recruitment pain points. They also partner with leading provider networks and pharmaceutical companies to expand access to clinical trials and leverage diverse datasets for building accurate AI models.
What the Web Says
Iterative Health, formerly Iterative Scopes, is a healthcare technology and services company that uses AI to accelerate clinical research and improve gastroenterology care. They offer products like SKOUT for real-time polyp detection and AI Recruitment for clinical trial patient identification. The company is generally viewed as mission-driven with strong compensation and benefits, but some employees note challenges associated with a fast-growing startup environment, such as shifting priorities and heavy workloads.
Overall: MixedStrengths
- Mission-driven work with a focus on transforming gastroenterology care and accelerating clinical research using AI.
- Strong compensation and comprehensive benefits package.
- Opportunity to make a significant impact and be part of building something new.
- Positive culture with outstanding colleagues and a collaborative environment.
- Interesting and evolving work that prevents boredom.
- Good tech for employees, cool office, and stocked kitchen.
Limitations
- Fast-moving environment with shifting priorities and many moving parts, which can be overwhelming.
- Potential for heavy workloads and intensity, leading to burnout.
- Process bottlenecks and a need for greater cohesion across teams and the organization.
- Periods of layoff anxiety and volatility have been referenced.
- Initial onboarding may require more technical expert help, prolonging the process.
- Limited customization in reporting modules.
Based on reviews from: Business Wire, Iterative Health (iterative.health), PitchBook, Indeed, Simply Hired, Built In, G2
Last updated: 2026-10-30
Videos
News, demos, and interviews about Iterative Health.
Videos load interactively. If none appear, search YouTube for Iterative Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Iterative Health.
Related Companies
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]
Cosmo Artificial Intelligence (Cosmo AI) is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. The company focuses on developing and manufacturing innovative, high-quality products and technologies, particularly those supported by AI and digital health, to enhance healthcare delivery. Cosmo AI’s mission is to empower patients, healthcare professionals, and partners by innovating at […]
Exact Sciences is a molecular diagnostics company dedicated to the early detection and prevention of cancer, as well as guiding treatment decisions. The company is best known for its non-invasive colorectal cancer screening test, Cologuard, which analyzes stool samples for DNA markers and occult hemoglobin to assess a patient’s risk of colorectal cancer. Cologuard was […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]
Motus GI Holdings, Inc. is a medical technology company that develops innovative solutions for gastrointestinal procedures, primarily focusing on enhancing colonoscopy outcomes. Their flagship product, the Pure-Vu System, is a U.S. FDA-cleared and CE-marked medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy procedures. The […]
Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio […]